Author name: saylakhan

IdeSHi Joins the Global HPV Consortium of the Sabin Vaccine Institute 

We are delighted to announce that IdeSHi, the Institute for Developing Science and Health Initiatives, has become a partner of the Global HPV Consortium, led by the Sabin Vaccine Institute. This partnership marks an important step in the battle against Human Papillomavirus (HPV), a major public health issue. IdeSHi’s role in medical research and its […]

IdeSHi Joins the Global HPV Consortium of the Sabin Vaccine Institute  Read More »

Ranibizumab Clinical Trial Inauguration Program

On December 3rd, 2023 ideshi in association with Bangladesh Eye Hospital launched “The Efficacy and Safety study of Ranibizumab”  inauguration meeting.     The Principal Investigator, all Co-investigators, CRO, representative from sponsor  were present in the meeting. Training session was conducted on overall study protocol, Case Record Form, Logs and Documentation, Quality management of sample

Ranibizumab Clinical Trial Inauguration Program Read More »

BRCA mutation in women with high-grade epithelial Ovarian Cancer

Program Lead Dr. Mohammad Tanbir Habib Communication Mahin Hasan ([email protected]) Abstract BRCA1 and BRCA2 are tumor-suppressing genes, required by the DNA damage-repairing pathway to maintain genomic stability. Malfunctioning of the BRCA1 or BRCA2 gene via hereditary or somatic mutation can cause breast/ovarian cancer. Approximately 15% to 20% of all women with invasive ovarian cancer carry

BRCA mutation in women with high-grade epithelial Ovarian Cancer Read More »

Antimicrobial Resistance (AMR): A Silent Killer

To observe World AMR Awareness Week 2023, 18 – 24 November, Dr. Zannat Kawser and Sanchita Kar from ideSHi attended a seminar arranged by IEDCR.           From left Dr. Zannat Kawser, Assistant Scientist ideSHi, Dr. Nandita Banik, National Consultant of Microbiology, WHO, Prof. Lovely Barai, Department of Microbiology, BIRDEM and Sanchita Kar,

Antimicrobial Resistance (AMR): A Silent Killer Read More »

HPV Infection, Vaccination, and Cervical Cancer Awareness: A roadmap to Eliminate Cervical Cancer in Bangladesh

As a regular awareness program, we have visited two madrasahs recently Baitul Mosharraf Senior Madrasah & Darul Uloom Mahila Madrasah. We are delighted by the warm welcome of the teachers, students and the parents. Cervical cancer is preventable but the awareness is not enough and the knowledge is the key to a healthier future. Keeping

HPV Infection, Vaccination, and Cervical Cancer Awareness: A roadmap to Eliminate Cervical Cancer in Bangladesh Read More »

Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh

Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh

Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh Read More »

Scroll to Top